Gerald Dodd
Concepts (377)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiology | 15 | 2017 | 180 | 4.860 |
Why?
| | Catheter Ablation | 30 | 2016 | 350 | 3.360 |
Why?
| | Liver | 30 | 2016 | 1943 | 1.870 |
Why?
| | Portal Vein | 12 | 2016 | 120 | 1.830 |
Why?
| | Liver Neoplasms | 34 | 2012 | 786 | 1.810 |
Why?
| | Tomography, X-Ray Computed | 51 | 2015 | 2691 | 1.550 |
Why?
| | Diagnostic Imaging | 8 | 2017 | 332 | 1.180 |
Why?
| | Carcinoma, Hepatocellular | 16 | 2005 | 362 | 1.070 |
Why?
| | Liver Cirrhosis | 18 | 2003 | 316 | 1.070 |
Why?
| | Blood Flow Velocity | 6 | 2016 | 413 | 1.040 |
Why?
| | Microwaves | 6 | 2015 | 37 | 1.000 |
Why?
| | Liver Circulation | 7 | 2016 | 20 | 0.960 |
Why?
| | Societies, Medical | 4 | 2013 | 820 | 0.910 |
Why?
| | Hepatectomy | 4 | 2016 | 251 | 0.900 |
Why?
| | Models, Organizational | 3 | 2016 | 151 | 0.900 |
Why?
| | Students, Medical | 2 | 2017 | 348 | 0.680 |
Why?
| | Organizational Objectives | 3 | 2015 | 73 | 0.660 |
Why?
| | Computer-Assisted Instruction | 2 | 2013 | 66 | 0.640 |
Why?
| | Internet | 2 | 2013 | 655 | 0.580 |
Why?
| | Delivery of Health Care | 2 | 2016 | 951 | 0.580 |
Why?
| | Internship and Residency | 4 | 2013 | 1147 | 0.560 |
Why?
| | Radiology Information Systems | 1 | 2016 | 30 | 0.510 |
Why?
| | Biotechnology | 1 | 2016 | 42 | 0.500 |
Why?
| | Fasciola hepatica | 1 | 2015 | 3 | 0.490 |
Why?
| | Laboratories | 1 | 2017 | 113 | 0.490 |
Why?
| | Fascioliasis | 1 | 2015 | 4 | 0.490 |
Why?
| | Contrast Media | 12 | 2015 | 467 | 0.480 |
Why?
| | Organizational Innovation | 1 | 2016 | 140 | 0.480 |
Why?
| | Cattle | 8 | 2016 | 984 | 0.470 |
Why?
| | Private Sector | 1 | 2015 | 52 | 0.460 |
Why?
| | Personal Satisfaction | 1 | 2017 | 207 | 0.450 |
Why?
| | Prostate | 1 | 2015 | 175 | 0.440 |
Why?
| | Radiology Department, Hospital | 1 | 2014 | 16 | 0.430 |
Why?
| | Health Care Reform | 1 | 2015 | 107 | 0.430 |
Why?
| | Editorial Policies | 1 | 2014 | 52 | 0.420 |
Why?
| | Biological Science Disciplines | 1 | 2013 | 17 | 0.420 |
Why?
| | Education, Graduate | 1 | 2013 | 34 | 0.410 |
Why?
| | Hepatic Veins | 4 | 2000 | 33 | 0.410 |
Why?
| | Education, Medical | 2 | 2014 | 266 | 0.410 |
Why?
| | Curriculum | 3 | 2017 | 992 | 0.410 |
Why?
| | Computers, Handheld | 1 | 2013 | 25 | 0.410 |
Why?
| | Program Evaluation | 2 | 2017 | 898 | 0.400 |
Why?
| | Schools, Medical | 1 | 2014 | 147 | 0.400 |
Why?
| | Advisory Committees | 1 | 2014 | 219 | 0.400 |
Why?
| | Hemangioma, Cavernous | 1 | 2012 | 15 | 0.390 |
Why?
| | Publishing | 1 | 2014 | 147 | 0.390 |
Why?
| | Periodicals as Topic | 1 | 2014 | 211 | 0.370 |
Why?
| | International Cooperation | 1 | 2012 | 198 | 0.360 |
Why?
| | Efficiency, Organizational | 2 | 2015 | 140 | 0.350 |
Why?
| | Ultrasonography, Interventional | 5 | 2001 | 141 | 0.340 |
Why?
| | Ultrasonography | 19 | 2013 | 759 | 0.340 |
Why?
| | Research Support as Topic | 2 | 2010 | 119 | 0.330 |
Why?
| | Societies, Scientific | 1 | 2010 | 51 | 0.330 |
Why?
| | Mobile Applications | 1 | 2013 | 183 | 0.330 |
Why?
| | Thrombosis | 6 | 1997 | 371 | 0.330 |
Why?
| | Education | 1 | 2010 | 108 | 0.320 |
Why?
| | Minimally Invasive Surgical Procedures | 3 | 2001 | 179 | 0.320 |
Why?
| | United States | 12 | 2016 | 14841 | 0.310 |
Why?
| | Portasystemic Shunt, Transjugular Intrahepatic | 3 | 2000 | 44 | 0.310 |
Why?
| | Cooperative Behavior | 1 | 2012 | 451 | 0.310 |
Why?
| | Magnetic Resonance Imaging | 14 | 2013 | 3566 | 0.300 |
Why?
| | Sensitivity and Specificity | 14 | 2016 | 1946 | 0.300 |
Why?
| | Diverticulitis, Colonic | 2 | 1999 | 7 | 0.300 |
Why?
| | Colonic Neoplasms | 3 | 2004 | 258 | 0.290 |
Why?
| | Cholelithiasis | 2 | 1999 | 38 | 0.290 |
Why?
| | Research | 2 | 2010 | 451 | 0.280 |
Why?
| | In Vitro Techniques | 5 | 2016 | 1092 | 0.270 |
Why?
| | Cholangitis, Sclerosing | 2 | 1999 | 75 | 0.270 |
Why?
| | Middle Aged | 53 | 2015 | 33479 | 0.270 |
Why?
| | Humans | 95 | 2017 | 137585 | 0.260 |
Why?
| | Hepatic Artery | 3 | 1996 | 62 | 0.260 |
Why?
| | Imaging, Three-Dimensional | 4 | 2016 | 580 | 0.260 |
Why?
| | Terminology as Topic | 4 | 2014 | 216 | 0.250 |
Why?
| | Cryosurgery | 2 | 2004 | 59 | 0.250 |
Why?
| | Lymph Nodes | 3 | 1997 | 491 | 0.250 |
Why?
| | Lipoma | 3 | 1990 | 16 | 0.250 |
Why?
| | Videoconferencing | 1 | 2006 | 66 | 0.250 |
Why?
| | Liver Transplantation | 6 | 1996 | 871 | 0.240 |
Why?
| | Leiomyoma | 3 | 1990 | 77 | 0.230 |
Why?
| | Postoperative Complications | 7 | 2005 | 2654 | 0.230 |
Why?
| | Neoplasms | 7 | 2014 | 2671 | 0.230 |
Why?
| | Electrocoagulation | 2 | 2001 | 40 | 0.220 |
Why?
| | Teaching | 1 | 2006 | 224 | 0.220 |
Why?
| | Aged | 36 | 2015 | 23961 | 0.220 |
Why?
| | History, 21st Century | 2 | 2016 | 213 | 0.210 |
Why?
| | History, 20th Century | 2 | 2016 | 325 | 0.200 |
Why?
| | Female | 56 | 2017 | 73304 | 0.200 |
Why?
| | Cholangiography | 2 | 2000 | 17 | 0.200 |
Why?
| | Computer Simulation | 2 | 2010 | 978 | 0.190 |
Why?
| | Phantoms, Imaging | 2 | 2014 | 152 | 0.190 |
Why?
| | Perfusion | 3 | 2012 | 213 | 0.190 |
Why?
| | Electric Injuries | 1 | 2001 | 2 | 0.190 |
Why?
| | Forecasting | 2 | 2014 | 389 | 0.180 |
Why?
| | Ultrasonography, Doppler, Duplex | 3 | 1995 | 43 | 0.180 |
Why?
| | Information Dissemination | 2 | 2014 | 218 | 0.170 |
Why?
| | Male | 53 | 2017 | 67762 | 0.170 |
Why?
| | Animals | 14 | 2016 | 36940 | 0.170 |
Why?
| | Cystadenocarcinoma, Papillary | 1 | 2000 | 5 | 0.170 |
Why?
| | Carcinoma, Squamous Cell | 3 | 2011 | 683 | 0.170 |
Why?
| | Head and Neck Neoplasms | 3 | 2011 | 606 | 0.170 |
Why?
| | Iopanoic Acid | 1 | 2000 | 1 | 0.170 |
Why?
| | Congresses as Topic | 2 | 2013 | 233 | 0.160 |
Why?
| | Radiography | 6 | 2012 | 822 | 0.160 |
Why?
| | Adult | 36 | 2017 | 37929 | 0.160 |
Why?
| | Ultrasonography, Doppler, Color | 2 | 2016 | 39 | 0.160 |
Why?
| | Radiography, Interventional | 3 | 2014 | 116 | 0.160 |
Why?
| | Kidney Transplantation | 5 | 1993 | 708 | 0.160 |
Why?
| | Equipment Design | 3 | 2016 | 522 | 0.160 |
Why?
| | Peritoneal Neoplasms | 1 | 2000 | 93 | 0.160 |
Why?
| | Liver Cirrhosis, Biliary | 1 | 1999 | 18 | 0.160 |
Why?
| | Uterine Neoplasms | 2 | 1990 | 109 | 0.150 |
Why?
| | Doxorubicin | 2 | 2011 | 362 | 0.150 |
Why?
| | Chemoembolization, Therapeutic | 1 | 2000 | 91 | 0.150 |
Why?
| | Image Processing, Computer-Assisted | 7 | 2008 | 752 | 0.140 |
Why?
| | Radiography, Abdominal | 2 | 1999 | 45 | 0.140 |
Why?
| | Arterial Occlusive Diseases | 2 | 1996 | 83 | 0.140 |
Why?
| | Radiation Exposure | 1 | 2017 | 49 | 0.130 |
Why?
| | Renal Artery Obstruction | 3 | 1995 | 30 | 0.130 |
Why?
| | Intergenerational Relations | 1 | 2017 | 23 | 0.130 |
Why?
| | Hemangioma | 1 | 1997 | 48 | 0.130 |
Why?
| | Inventions | 1 | 2016 | 20 | 0.130 |
Why?
| | Infarction | 1 | 1996 | 10 | 0.130 |
Why?
| | Models, Anatomic | 1 | 2016 | 93 | 0.130 |
Why?
| | Equipment Failure Analysis | 1 | 2016 | 132 | 0.130 |
Why?
| | Biopsy, Needle | 5 | 1996 | 189 | 0.120 |
Why?
| | Prospective Studies | 11 | 2005 | 7604 | 0.120 |
Why?
| | alpha-Fetoproteins | 1 | 1996 | 46 | 0.120 |
Why?
| | Organ Size | 1 | 2016 | 477 | 0.120 |
Why?
| | Ovarian Neoplasms | 3 | 1990 | 565 | 0.120 |
Why?
| | Portasystemic Shunt, Surgical | 1 | 1995 | 3 | 0.120 |
Why?
| | Hepatic Veno-Occlusive Disease | 1 | 1995 | 14 | 0.120 |
Why?
| | Treatment Outcome | 6 | 2016 | 10811 | 0.120 |
Why?
| | Awards and Prizes | 1 | 2016 | 67 | 0.120 |
Why?
| | Ultrasonography, Doppler | 1 | 1995 | 124 | 0.120 |
Why?
| | Texas | 2 | 2013 | 244 | 0.110 |
Why?
| | Program Development | 1 | 2017 | 364 | 0.110 |
Why?
| | Radiology, Interventional | 1 | 2014 | 33 | 0.110 |
Why?
| | Constriction, Pathologic | 4 | 1996 | 245 | 0.110 |
Why?
| | Education, Medical, Undergraduate | 1 | 2017 | 188 | 0.110 |
Why?
| | Ablation Techniques | 1 | 2014 | 36 | 0.110 |
Why?
| | Bile Duct Diseases | 1 | 1994 | 14 | 0.110 |
Why?
| | Radiopharmaceuticals | 2 | 2011 | 178 | 0.110 |
Why?
| | Research Design | 2 | 2014 | 1139 | 0.110 |
Why?
| | Neoplasm Invasiveness | 1 | 1995 | 510 | 0.110 |
Why?
| | Dermoid Cyst | 2 | 1990 | 15 | 0.110 |
Why?
| | Angiography | 3 | 2000 | 207 | 0.110 |
Why?
| | Portography | 5 | 2000 | 12 | 0.110 |
Why?
| | Reproducibility of Results | 4 | 2016 | 3284 | 0.100 |
Why?
| | Time Factors | 10 | 2015 | 6828 | 0.100 |
Why?
| | Diagnosis, Differential | 7 | 2002 | 1483 | 0.100 |
Why?
| | Radio Waves | 1 | 2013 | 18 | 0.100 |
Why?
| | Cysts | 1 | 1994 | 113 | 0.100 |
Why?
| | Linear Models | 2 | 2013 | 849 | 0.100 |
Why?
| | Bile Ducts, Intrahepatic | 3 | 2000 | 78 | 0.100 |
Why?
| | Information Services | 1 | 2013 | 49 | 0.100 |
Why?
| | Esophageal Neoplasms | 1 | 1997 | 321 | 0.100 |
Why?
| | Social Networking | 1 | 2013 | 33 | 0.100 |
Why?
| | Industry | 1 | 2013 | 68 | 0.100 |
Why?
| | Thoracic Diseases | 1 | 1992 | 14 | 0.100 |
Why?
| | Planning Techniques | 1 | 2012 | 16 | 0.100 |
Why?
| | Transplantation | 1 | 1992 | 34 | 0.100 |
Why?
| | Colorectal Neoplasms | 4 | 2009 | 806 | 0.090 |
Why?
| | Lymphoproliferative Disorders | 1 | 1992 | 57 | 0.090 |
Why?
| | Rhenium | 1 | 2011 | 4 | 0.090 |
Why?
| | Radiation Protection | 1 | 2012 | 38 | 0.090 |
Why?
| | Neoplasm Staging | 3 | 2001 | 1389 | 0.090 |
Why?
| | Retrospective Studies | 15 | 2007 | 15657 | 0.090 |
Why?
| | Data Collection | 1 | 2014 | 673 | 0.090 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2011 | 127 | 0.090 |
Why?
| | Varicose Veins | 1 | 1991 | 17 | 0.090 |
Why?
| | Alberta | 1 | 2010 | 26 | 0.090 |
Why?
| | Educational Measurement | 1 | 2013 | 289 | 0.090 |
Why?
| | Vascular Diseases | 2 | 2004 | 243 | 0.090 |
Why?
| | Radiation Dosage | 1 | 2012 | 179 | 0.080 |
Why?
| | Education, Continuing | 1 | 2010 | 39 | 0.080 |
Why?
| | Liposarcoma | 1 | 1990 | 27 | 0.080 |
Why?
| | Therapy, Computer-Assisted | 1 | 2010 | 62 | 0.080 |
Why?
| | Forensic Medicine | 1 | 1990 | 18 | 0.080 |
Why?
| | Orbit | 1 | 1991 | 70 | 0.080 |
Why?
| | Documentation | 1 | 2012 | 194 | 0.080 |
Why?
| | Hospitals, Teaching | 1 | 2010 | 118 | 0.080 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 2010 | 80 | 0.080 |
Why?
| | Diaphragm | 2 | 2007 | 42 | 0.080 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2012 | 267 | 0.080 |
Why?
| | Combined Modality Therapy | 3 | 2011 | 1236 | 0.080 |
Why?
| | Education, Medical, Continuing | 1 | 2010 | 127 | 0.080 |
Why?
| | ROC Curve | 2 | 2005 | 554 | 0.080 |
Why?
| | Professional-Patient Relations | 1 | 2010 | 145 | 0.080 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2017 | 1329 | 0.080 |
Why?
| | Oxygen Radioisotopes | 1 | 2008 | 3 | 0.080 |
Why?
| | Physicians | 1 | 2017 | 910 | 0.080 |
Why?
| | Leadership | 1 | 2013 | 388 | 0.070 |
Why?
| | Sigmoid Diseases | 2 | 1999 | 12 | 0.070 |
Why?
| | Mesentery | 2 | 1999 | 48 | 0.070 |
Why?
| | Patient Selection | 2 | 2004 | 696 | 0.070 |
Why?
| | Kidney | 3 | 1993 | 1468 | 0.070 |
Why?
| | Iopamidol | 4 | 1995 | 17 | 0.070 |
Why?
| | Shoulder Pain | 1 | 2007 | 34 | 0.070 |
Why?
| | Positron-Emission Tomography | 1 | 2008 | 294 | 0.070 |
Why?
| | Computer Communication Networks | 1 | 2006 | 33 | 0.060 |
Why?
| | Wounds, Gunshot | 1 | 1990 | 228 | 0.060 |
Why?
| | Rats, Nude | 3 | 2011 | 26 | 0.060 |
Why?
| | Colorado | 2 | 2013 | 4565 | 0.060 |
Why?
| | Chills | 1 | 2005 | 2 | 0.060 |
Why?
| | Clinical Trials as Topic | 3 | 2009 | 1050 | 0.060 |
Why?
| | Liver Diseases | 3 | 1996 | 315 | 0.060 |
Why?
| | Antineoplastic Agents | 2 | 2010 | 2129 | 0.060 |
Why?
| | Syndrome | 1 | 2005 | 358 | 0.060 |
Why?
| | Colon | 2 | 2004 | 282 | 0.050 |
Why?
| | Emergency Service, Hospital | 1 | 2015 | 2069 | 0.050 |
Why?
| | Abdominal Neoplasms | 1 | 2004 | 39 | 0.050 |
Why?
| | Fever | 1 | 2005 | 306 | 0.050 |
Why?
| | Aged, 80 and over | 6 | 2007 | 7635 | 0.050 |
Why?
| | Radiographic Image Enhancement | 2 | 2000 | 58 | 0.050 |
Why?
| | Models, Biological | 1 | 2010 | 1783 | 0.050 |
Why?
| | Laser Therapy | 2 | 2003 | 130 | 0.050 |
Why?
| | Follow-Up Studies | 4 | 2005 | 5131 | 0.050 |
Why?
| | Education, Medical, Graduate | 1 | 2007 | 486 | 0.050 |
Why?
| | Predictive Value of Tests | 3 | 2000 | 2031 | 0.050 |
Why?
| | Doppler Effect | 1 | 2002 | 3 | 0.050 |
Why?
| | Adolescent | 9 | 2004 | 21513 | 0.050 |
Why?
| | Retroperitoneal Space | 2 | 1999 | 20 | 0.050 |
Why?
| | Monitoring, Intraoperative | 1 | 2002 | 56 | 0.050 |
Why?
| | Stents | 2 | 1997 | 527 | 0.050 |
Why?
| | Cholecystostomy | 1 | 2001 | 4 | 0.040 |
Why?
| | Cholecystitis | 1 | 2001 | 24 | 0.040 |
Why?
| | Suction | 1 | 2001 | 34 | 0.040 |
Why?
| | Multiple Trauma | 1 | 2001 | 100 | 0.040 |
Why?
| | Cholecystography | 1 | 2000 | 2 | 0.040 |
Why?
| | Cystic Duct | 1 | 2000 | 4 | 0.040 |
Why?
| | Hepatic Duct, Common | 1 | 2000 | 6 | 0.040 |
Why?
| | Pelvic Neoplasms | 1 | 2000 | 26 | 0.040 |
Why?
| | Diathermy | 1 | 2000 | 2 | 0.040 |
Why?
| | Common Bile Duct | 1 | 2000 | 18 | 0.040 |
Why?
| | Models, Animal | 2 | 2012 | 384 | 0.040 |
Why?
| | Stomach | 1 | 2000 | 110 | 0.040 |
Why?
| | Feasibility Studies | 2 | 2003 | 956 | 0.040 |
Why?
| | Cholecystectomy | 1 | 2000 | 62 | 0.040 |
Why?
| | Liver Regeneration | 1 | 1999 | 46 | 0.040 |
Why?
| | Omentum | 1 | 1999 | 10 | 0.040 |
Why?
| | Laser Coagulation | 1 | 2000 | 68 | 0.040 |
Why?
| | Artifacts | 1 | 2000 | 129 | 0.040 |
Why?
| | False Negative Reactions | 1 | 1999 | 53 | 0.040 |
Why?
| | Neoplasm Transplantation | 2 | 2010 | 257 | 0.040 |
Why?
| | Embolization, Therapeutic | 1 | 2001 | 229 | 0.040 |
Why?
| | Image Enhancement | 1 | 2000 | 190 | 0.040 |
Why?
| | Algorithms | 3 | 2010 | 1704 | 0.040 |
Why?
| | Portal System | 2 | 1995 | 14 | 0.040 |
Why?
| | Edema | 1 | 1999 | 130 | 0.040 |
Why?
| | Iothalamate Meglumine | 2 | 1996 | 4 | 0.040 |
Why?
| | Analysis of Variance | 2 | 2011 | 1316 | 0.040 |
Why?
| | Neoplastic Cells, Circulating | 2 | 1996 | 80 | 0.040 |
Why?
| | Perioperative Care | 1 | 1999 | 178 | 0.030 |
Why?
| | Risk Assessment | 1 | 2007 | 3457 | 0.030 |
Why?
| | Administration, Oral | 1 | 2000 | 816 | 0.030 |
Why?
| | Bile Ducts, Extrahepatic | 1 | 1997 | 22 | 0.030 |
Why?
| | Rats | 3 | 2011 | 5647 | 0.030 |
Why?
| | Intestines | 1 | 2000 | 357 | 0.030 |
Why?
| | Adenocarcinoma | 1 | 2004 | 940 | 0.030 |
Why?
| | Punctures | 1 | 1996 | 40 | 0.030 |
Why?
| | Appendix | 1 | 1997 | 30 | 0.030 |
Why?
| | Ureteral Obstruction | 2 | 1994 | 64 | 0.030 |
Why?
| | Anesthesia | 1 | 1999 | 189 | 0.030 |
Why?
| | Kidney Diseases | 2 | 2004 | 408 | 0.030 |
Why?
| | Ascites | 1 | 1996 | 46 | 0.030 |
Why?
| | Colonic Polyps | 1 | 1997 | 88 | 0.030 |
Why?
| | Drainage | 1 | 1996 | 173 | 0.030 |
Why?
| | Injections, Intravenous | 2 | 2010 | 206 | 0.030 |
Why?
| | Triiodobenzoic Acids | 3 | 2001 | 9 | 0.030 |
Why?
| | Pulsatile Flow | 1 | 1995 | 60 | 0.030 |
Why?
| | Regional Blood Flow | 2 | 2003 | 474 | 0.030 |
Why?
| | Appendicitis | 1 | 1997 | 130 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 1999 | 1509 | 0.030 |
Why?
| | Radionuclide Imaging | 2 | 2011 | 118 | 0.030 |
Why?
| | Colic | 1 | 1994 | 8 | 0.030 |
Why?
| | Vascular Patency | 1 | 1995 | 106 | 0.030 |
Why?
| | Risk | 1 | 2017 | 912 | 0.030 |
Why?
| | Peripheral Vascular Diseases | 1 | 1995 | 103 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2001 | 1079 | 0.030 |
Why?
| | Systole | 1 | 1994 | 189 | 0.030 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 1995 | 132 | 0.030 |
Why?
| | Population Surveillance | 1 | 1997 | 482 | 0.030 |
Why?
| | Cholangiocarcinoma | 1 | 1994 | 104 | 0.030 |
Why?
| | Bile Duct Neoplasms | 1 | 1994 | 124 | 0.030 |
Why?
| | Hyperthermia, Induced | 2 | 2005 | 116 | 0.030 |
Why?
| | Vascular Resistance | 1 | 1994 | 375 | 0.030 |
Why?
| | Hemangioendothelioma | 1 | 1992 | 15 | 0.020 |
Why?
| | Recurrence | 1 | 1996 | 1060 | 0.020 |
Why?
| | NADPH Dehydrogenase | 1 | 2012 | 7 | 0.020 |
Why?
| | Pilot Projects | 1 | 2017 | 1710 | 0.020 |
Why?
| | Nuclear Medicine | 1 | 2011 | 9 | 0.020 |
Why?
| | Tromethamine | 1 | 2011 | 2 | 0.020 |
Why?
| | Staining and Labeling | 1 | 2012 | 150 | 0.020 |
Why?
| | Risk Factors | 4 | 2007 | 10388 | 0.020 |
Why?
| | Transplantation, Heterologous | 1 | 2011 | 194 | 0.020 |
Why?
| | Isotope Labeling | 1 | 2011 | 81 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 1993 | 363 | 0.020 |
Why?
| | Random Allocation | 1 | 2011 | 353 | 0.020 |
Why?
| | Drug Synergism | 1 | 2011 | 382 | 0.020 |
Why?
| | Acute Disease | 3 | 2001 | 1007 | 0.020 |
Why?
| | Finite Element Analysis | 1 | 2010 | 75 | 0.020 |
Why?
| | Technetium Tc 99m Pentetate | 1 | 2010 | 7 | 0.020 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2011 | 389 | 0.020 |
Why?
| | Liposomes | 1 | 2011 | 223 | 0.020 |
Why?
| | Materials Testing | 1 | 2011 | 356 | 0.020 |
Why?
| | Tissue Distribution | 1 | 2010 | 332 | 0.020 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2010 | 110 | 0.020 |
Why?
| | Infant | 2 | 1994 | 9465 | 0.020 |
Why?
| | Swine | 1 | 2011 | 775 | 0.020 |
Why?
| | Child, Preschool | 2 | 1994 | 11074 | 0.020 |
Why?
| | Efficiency | 1 | 2007 | 99 | 0.020 |
Why?
| | Personnel Selection | 1 | 2007 | 78 | 0.020 |
Why?
| | Health Status Disparities | 1 | 2009 | 289 | 0.020 |
Why?
| | Glucose | 1 | 2011 | 1020 | 0.020 |
Why?
| | Heart Transplantation | 1 | 1992 | 754 | 0.020 |
Why?
| | Hemorrhage | 2 | 2004 | 722 | 0.020 |
Why?
| | Child | 3 | 1994 | 21935 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2017 | 5778 | 0.010 |
Why?
| | Lasers | 1 | 2005 | 130 | 0.010 |
Why?
| | Medical Records | 1 | 2005 | 177 | 0.010 |
Why?
| | Models, Statistical | 1 | 2008 | 669 | 0.010 |
Why?
| | Neoplasm Seeding | 1 | 2004 | 7 | 0.010 |
Why?
| | Adrenal Gland Diseases | 1 | 2004 | 6 | 0.010 |
Why?
| | Intestinal Perforation | 1 | 2004 | 46 | 0.010 |
Why?
| | Prognosis | 1 | 1992 | 4030 | 0.010 |
Why?
| | Intestinal Obstruction | 1 | 2004 | 51 | 0.010 |
Why?
| | Ultrasonic Therapy | 1 | 2003 | 15 | 0.010 |
Why?
| | Cryotherapy | 1 | 2003 | 17 | 0.010 |
Why?
| | Gallbladder | 1 | 2003 | 19 | 0.010 |
Why?
| | Hot Temperature | 1 | 2005 | 391 | 0.010 |
Why?
| | Necrosis | 1 | 2002 | 246 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2011 | 4295 | 0.010 |
Why?
| | Venous Pressure | 1 | 2000 | 8 | 0.010 |
Why?
| | Incidence | 1 | 2007 | 2804 | 0.010 |
Why?
| | Jejunum | 1 | 2000 | 31 | 0.010 |
Why?
| | Postanesthesia Nursing | 1 | 1999 | 2 | 0.010 |
Why?
| | Duodenum | 1 | 2000 | 78 | 0.010 |
Why?
| | Equipment Failure | 1 | 2000 | 108 | 0.010 |
Why?
| | Peritoneal Diseases | 1 | 1999 | 4 | 0.010 |
Why?
| | Single-Blind Method | 1 | 2000 | 282 | 0.010 |
Why?
| | Ileum | 1 | 2000 | 119 | 0.010 |
Why?
| | Confidence Intervals | 1 | 2000 | 329 | 0.010 |
Why?
| | Burns | 1 | 2004 | 325 | 0.010 |
Why?
| | Observer Variation | 1 | 2000 | 343 | 0.010 |
Why?
| | Statistics as Topic | 1 | 2000 | 307 | 0.010 |
Why?
| | Contraindications | 1 | 1996 | 90 | 0.010 |
Why?
| | Hematocrit | 1 | 1996 | 96 | 0.010 |
Why?
| | Comorbidity | 1 | 2001 | 1622 | 0.010 |
Why?
| | Abdomen | 1 | 1996 | 125 | 0.010 |
Why?
| | Needles | 1 | 1996 | 59 | 0.010 |
Why?
| | Pelvis | 1 | 1996 | 102 | 0.010 |
Why?
| | Lymphatic Metastasis | 1 | 1996 | 352 | 0.010 |
Why?
| | Heart Failure | 1 | 1988 | 2236 | 0.010 |
Why?
| | Reference Values | 1 | 1997 | 816 | 0.010 |
Why?
| | Injections, Intra-Arterial | 1 | 1994 | 27 | 0.010 |
Why?
| | Splenic Artery | 1 | 1994 | 14 | 0.010 |
Why?
| | Urography | 1 | 1994 | 17 | 0.010 |
Why?
| | Hemodynamics | 1 | 2000 | 1113 | 0.010 |
Why?
| | Mesenteric Artery, Superior | 1 | 1994 | 17 | 0.010 |
Why?
| | Evaluation Studies as Topic | 1 | 1995 | 180 | 0.010 |
Why?
| | False Positive Reactions | 1 | 1995 | 115 | 0.010 |
Why?
| | Pentetic Acid | 1 | 1993 | 13 | 0.010 |
Why?
| | Meglumine | 1 | 1993 | 18 | 0.010 |
Why?
| | Osmolar Concentration | 1 | 1994 | 171 | 0.010 |
Why?
| | Hemoglobins | 1 | 1996 | 353 | 0.010 |
Why?
| | Gadolinium DTPA | 1 | 1993 | 70 | 0.010 |
Why?
| | Catheterization, Peripheral | 1 | 1994 | 109 | 0.010 |
Why?
| | Gadolinium | 1 | 1993 | 82 | 0.010 |
Why?
| | Blood Transfusion | 1 | 1996 | 325 | 0.010 |
Why?
| | Adenoma, Bile Duct | 1 | 1992 | 1 | 0.010 |
Why?
| | Organometallic Compounds | 1 | 1993 | 111 | 0.010 |
Why?
| | Drug Combinations | 1 | 1993 | 343 | 0.010 |
Why?
| | Hydronephrosis | 1 | 1992 | 36 | 0.010 |
Why?
| | Graft Survival | 1 | 1993 | 535 | 0.010 |
Why?
| | Biopsy | 1 | 1992 | 1129 | 0.000 |
Why?
| | Case-Control Studies | 1 | 1996 | 3556 | 0.000 |
Why?
| | Kidney Neoplasms | 1 | 1993 | 403 | 0.000 |
Why?
|
|
Dodd's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|